Open access
70
Views
7
CrossRef citations to date
0
Altmetric
Original Research
Baseline characteristics and initial treatment decisions for patients with schizophrenia at risk of treatment nonadherence
Katarina Kelin1 Eli Lilly Australia Pty Ltd, West Ryde, NSW, AustraliaCorrespondence[email protected]
, Alan JM Brnabic2 Intercontinental Information Sciences, Eli Lilly Australia Pty Ltd, Macquarie Park, NSW, Australia
, Richard Newton3 Peninsula Health Psychiatric Services, Frankston Hospital, Frankston, VIC, Australia (current affiliation: Department of Psychiatry, Austin Hospital, Heidelberg, VIC, Australia)
, Raúl I Escamilla4 Schizophrenia Clinic, National Institute of Psychiatry, Mexico City, México D.F
, Liang-Jen Chuo5 Department of Psychiatry, Taichung Veterans General Hospital, Taichung, Taiwan
, Malina Simu6 St Stelian Hospital, Bucharest, Romania
, Wenyu Ye2 Intercontinental Information Sciences, Eli Lilly Australia Pty Ltd, Macquarie Park, NSW, Australia
, William Montgomery1 Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia
, Jamie Karagianis7 Eli Lilly Canada Inc., Toronto, ON, Canada
& Haya Ascher-Svanum8 US Outcomes Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
show all
Pages 301-311
|
Published online: 11 Aug 2010
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.